Cologne and Ludwigshafen, Germany, May 15, 2013 Direvo Industrial Biotechnology GmbH (Direvo), an expert in enzyme development and optimization from Cologne, Germany and BASF SE, a global leader in sustainable animal nutrition, will jointly develop a highly efficient protease for pig and poultry nutrition. The global population growth, increasing [...]
Somatoprim reduces human growth hormone secretion safely and effectively in acromegaly patients Tel Aviv, Israel, 3rd April 2013: Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatoprim, a novel somatostatin analog (SSA), today announced results of a phase IIa study in acromegaly patients. The study [...]
WATERTOWN, Mass.–(BUSINESS WIRE)–Mar. 26, 2013– Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the closing of its initial public offering of 4,600,000 shares of its common stock at a price to the public of [...]
WATERTOWN, Mass., March 20, 2013 — Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public [...]
Today, Direvo Industrial Biotechnology GmbH (Direvo) announced the successful closure of a financing round of three and a half million Euro to fund the sustainable growth of the company. All current major investors participated in this third financing round since the founding of Direvo, a spin-off from Direvo Biotech AG, [...]
HALLE/SAALE, Germany–(BUSINESS WIRE)– Probiodrug AG (Probiodrug) today announced the appointment of two senior executives: Ronald Black, M.D., chief medical officer, and Inge Lues, Ph.D., chief development officer. Dr. Black will be based in the United States and will lead the Company’s clinical development strategy and U.S. presence. Dr. Lues will [...]
Montreal, January 22, 2013. TVM Life Science Ventures VII today announced an investment into Kaneq Bioscience Ltd. based in Montreal, Quebec. This company is a spin out of Kaneq Pharma Inc., a biotechnology company developing early stage compounds for metabolic diseases and cancer. Kaneq Bioscience Ltd. was specifically created to [...]
Preliminary Data Analysis Supports Excellent Safety and Side Effect Profile of Somatoprim Tel Aviv, Israel – 7th January 2013: Aspireo Pharmaceuticals Limited, (“Aspireo”) an Israeli biopharmaceutical company, focused on the development of Somatoprim, a novel somatostatin analog (SSA), today announced results of an interim analysis of a phase I b [...]
Amsterdam, December 17, 2012 Norgine BV (Amsterdam) and SpePharm Holding BV (Amsterdam) announced today that they have concluded a broad collaboration agreement under which the two companies have invested in a 50:50 joint venture, SpePharm AG, which has acquired the entire product portfolio of SpePharm Holding, including Savene®, MuGard®, Xerotin®, [...]
Berlin, Germany – 04 December 2012 – NOXXON Pharma today announced the treatment of the first patients in a Phase IIa clinical trial of its anti-hepcidin Spiegelmer® NOX-H94 to treat anemia associated with chronic disease. This PhaseIIa study was initiated following the successful completion of the clinical Phase I program, [...]